Work

Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene

Year: 2022

Type: article

Source: European Journal of Clinical Pharmacology

DOI: 10.1007/s00228-022-03302-5

Authors: David A. Nielsen, Robrina Walker, David P. Graham, Ellen M. Nielsen, Sara C. Hamon, Maureen Hillhouse, Dikla Shmueli-Blumberg, William B. Lawson, Kathy Shores-Wilson, Beverlyn D. Settles-Reaves, John Rotrosen, Madhukar H. Trivedi, Andrew J. Saxon, Walter Ling, Thomas R. Kosten

Institutions: Michael E. DeBakey VA Medical Center, Baylor College of Medicine, The University of Texas Southwestern Medical Center, University of California, Los Angeles, Emmes (United States), Howard University, New York University, University of Washington, VA Puget Sound Health Care System

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Drug Abuse

Awards: Innovative Multidisciplinary Education: The Statistical Genetics of Addiction, NIDA Clinical Trials Network - New York Node, G1886438392, The National Drug Abuse Treatment Clinical Trials Network, Stimulant Pharmacotherapy: Noradrenergic Targets, G7197319800, G8792963820

OpenAlex ID: W4214662056

FWCI: 0.404

Cites: 28

Cited by: 3

Related to: 10